secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001683168-25-000384
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio prices $2.5M registered direct offering of 833,335 shares at $3.00/sh; concurrent private placement of warrants
--------------------------------------------------------------------------------

- Gross proceeds of $2.5M; net ~$2.2M after fees and expenses.
- Issued 833,335 common shares at $3.00/sh in registered direct offering.
- Concurrent private placement of short-term warrants for up to 1,666,670 shares at $3.00, exercisable for 24 months.
- Placement agent H.C. Wainwright receives 62,500 warrants at $3.75/sh plus cash fees.
- Proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825000384/0001683168-25-000384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825000384/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer